Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of phenylephrine combinations for nasal congestion in the common cold
2015-002385-23Phase 3Completed
- Sponsor
- AFT Pharmaceuticals
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of phenylephrine, acetaminophen and ibuprofen in nasopharyngitis (4 arms), sponsored by AFT Pharmaceuticals. Primary endpoint: Area Under the Curve of Nasal Airflow Conductance from 0 to 4 hours after first dose. Started Sep 2015; status: completed.
02
Drugs
phenylephrineacetaminophenibuprofen
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on 2015-002385-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002385-23.